Podcasts about cytiva

The Future Of Biotech IT: AI, Cybersecurity & Low-Code Platforms | Steve Eichorn #biotech #aiinbiotech #cybersecurityHow is AI transforming the future of biotech today, not just in labs but in IT departments too? Please visit our website to get more information: https://swangroup.net/In this episode, I sit down with Steve Eichorn, CIO of Cytiva, to explore how artificial intelligence, cybersecurity, and low-code platforms are reshaping biotech from the inside out. Specifically, this episode highlights the following themes:✅ How AI is improving biotech operations and clinical processes✅ The growing importance of cybersecurity in an AI-driven world✅ Why low-code development is shaping the future of IT and business collaborationSteve shares his unique journey from finance to leading global IT and explains how AI is accelerating drug development, why low-code tools are changing how teams build solutions, and how security is now a core part of innovation. We also talk about how tech leaders are breaking down data silos, building more collaborative cultures, and preparing for the digital future of healthcare.If you're in biotech, tech, or healthcare, this conversation is full of insights you won't want to miss.Links from this episode:✅ Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup ✅ Get to know more about Steve Eichorn: https://www.linkedin.com/in/steve-eichorn-he-his-him-68b8105

Dr. Ron Beatson is the retired hop breeder who built a storied career at Plant & Food Research developing some of the most popular New Zealand hop varieties today, and Dr. Tom Shellhammer is the Oregon State University professor whose research into hop oils, hop terroir, hop-growing techniques, and more have made an indelible impact on the Pacific Northwest hop industry. Shellhammer is currently on a four-month sabbatical in New Zealand, studying the similarities and differences between U.S. and New Zealand hop practices, and presented at both the NZ Hops (https://nzhops.co.nz) Harfest event (with Dr. Ron Beatson) and on his own at the Freestyle Hops (https://www.freestylehops.com) Hāpi Symposium (https://hapi.co.nz). In this episode, we brought the two together to discuss: the hierarchy of impacts from genetics through terroir and agronomics differences in hops within a farm or area versus differences between areas the genesis of onion and garlic notes in hop aromas and flavors sources of inconsistency in a hop variety harvesting dynamics of Nelson Sauvin cover crops in hop fields to promote soil health multiple archetypes for hop varieties the source of “diesel” and “dank” notes in hops and the crossovers with cannabis thiol and terpene interactions in aroma formation over individual oil content impact from lack of disease in New Zealand hop fields soil and localized environmental impacts on New Zealand hop cultivation And more. This episode is brought to you by: G&D Chillers (https://gdchillers.com): G&D Chillers Elite 290 Micro-series line utilizes a natural refrigerant, features a more compact design with variable speed fans, and offers near-zero global warming potential. The future of sustainable refrigeration is here! Learn more about G&D's Elite 290 line and visit GDCHILLERS.COM. Berkeley Yeast (https://berkeleyyeast.com). Berkeley Yeast bioengineers ordinary strains and make them extraordinary—enhancing the flavors you want and eliminating the ones you don't. Visit berkeleyyeast.com to learn more and start brewing with science on your side. Old Orchard (https://www.oldorchard.com/brewer): As breweries expand beyond beer into other segments like mocktails and CBD beverages, Old Orchard is here to help. Whether trending flavor additions or nostalgic favorites, the next best thing is around the corner at Old Orchard. More information and free samples are waiting at oldorchard.com/brewer (https://www.oldorchard.com/brewer) Indie Hops (https://indiehops.com) Taste the modern flavors of Indie Hops at CBC, this year in Indianapolis. Join Indie in Indy for 14 incredible collab beers. Check out the full CBC beer lineup at www.indiehops.com and plan to stop by their booth #3122. Ss Brewtech (https://www.ssbrewtech.com) Featuring a laser-welded cooling jacket for efficient and precise temperature control, an innovative silicone racking arm, and a carbonation stone that allows you to carbonate right in the fermenter, Unitank 2.0 is engineered to help you get the most out of your fermentations! Visit Ss Brewtech.com (https://www.ssbrewtech.com) to learn more! Isuzu Trucks (https://www.isuzucv.com) Whether you are looking for a self-distribution solution or one to deliver supplies, there is an Isuzu truck that will fit your needs. Go to isuzucv.com (https://www.isuzucv.com) to check out their impressive lineup or visit an Isuzu dealer today to find out why now, more than ever, Isuzu trucks are the trucks you trust for the work you do! Cytiva (https://info.cytivalifesciences.com/sample-request-brewing.html) Protecting your beer's highest quality is crucial to maintain its unique taste and prevent spoilage organisms, and microbiological testing plays a vital role in this process. Cytiva offers a comprehensive portfolio of laboratory filtration products designed for both lab and production-floor use. Brewery Workshop (https://breweryworkshop.com) If you're launching a brewery or acquiring an existing one, consider our brewery workshop and new brewery accelerator, September 14 through 17th in Fort Collins, Colorado. Visit breweryworkshop.com for more information and to secure your spot.

Homogeneity is the name of the game in certain circles of brewing—from massive brewers who standardize their hop lots by blending before pelletizing, or hop companies that blend lots to iron out highs and lows in a particular crop year. But for Garage Project (https://garageproject.co.nz) and Hapi Research (https://hapi.co.nz)'s Pete Gillespie, that search for the least offensive middle way removes the incentive for everyone to optimize for quality, expression, and individuality that's core to the idea of craft beer. In their brewing program, and in their partnership to pursue new hop varieties, character and unique experiences are the name of the game, and they're putting significant investment behind the pursuit. In this episode, Gillespie discusses: using supporting hops to accentuate lead hop characters the impact of pick time on hop expression variations within single field blocks of hop varieties the dynamic shift in Nelson Sauvin over the picking window terroir's impact on hop flavors and aromas exploring diverse growing areas for hops in New Zealand surprise impact in this year's hops like Southern Cross the inscrutable challenge and benefit of Riwaka Hāpi Research's investment in developing new NZ varieties secrets of selecting Southern hemisphere hops And more. This episode is brought to you by: G&D Chillers (https://gdchillers.com): G&D Chillers Elite 290 Micro-series line utilizes a natural refrigerant, features a more compact design with variable speed fans, and offers near-zero global warming potential. The future of sustainable refrigeration is here! Learn more about G&D's Elite 290 line and visit GDCHILLERS.COM. Berkeley Yeast (https://berkeleyyeast.com). Berkeley Yeast bioengineers ordinary strains and make them extraordinary—enhancing the flavors you want and eliminating the ones you don't. Visit berkeleyyeast.com to learn more and start brewing with science on your side. Old Orchard (https://www.oldorchard.com/brewer): As breweries expand beyond beer into other segments like mocktails and CBD beverages, Old Orchard is here to help. Whether trending flavor additions or nostalgic favorites, the next best thing is around the corner at Old Orchard. More information and free samples are waiting at oldorchard.com/brewer (https://www.oldorchard.com/brewer) Indie Hops (https://indiehops.com) Taste the modern flavors of Indie Hops at CBC, this year in Indianapolis. Join Indie in Indy for 14 incredible collab beers. Check out the full CBC beer lineup at www.indiehops.com and plan to stop by their booth #3122. Ss Brewtech (https://www.ssbrewtech.com) Featuring a laser-welded cooling jacket for efficient and precise temperature control, an innovative silicone racking arm, and a carbonation stone that allows you to carbonate right in the fermenter, Unitank 2.0 is engineered to help you get the most out of your fermentations! Visit Ss Brewtech.com (https://www.ssbrewtech.com) to learn more! Isuzu Trucks (https://www.isuzucv.com) Whether you are looking for a self-distribution solution or one to deliver supplies, there is an Isuzu truck that will fit your needs. Go to isuzucv.com (https://www.isuzucv.com) to check out their impressive lineup or visit an Isuzu dealer today to find out why now, more than ever, Isuzu trucks are the trucks you trust for the work you do! Cytiva (https://info.cytivalifesciences.com/sample-request-brewing.html) Protecting your beer's highest quality is crucial to maintain its unique taste and prevent spoilage organisms, and microbiological testing plays a vital role in this process. Cytiva offers a comprehensive portfolio of laboratory filtration products designed for both lab and production-floor use. Brewery Workshop (https://breweryworkshop.com) If you're launching a brewery or acquiring an existing one, consider our brewery workshop and new brewery accelerator, September 14 through 17th in Fort Collins, Colorado. Visit breweryworkshop.com for more information and to secure your spot.

Earlier this week, our Industry All-Access (https://brewingindustryguide.com/subscription/) subscribers received in their email inbox this week's subscriber-exclusive article that Kate reported, parsing the latest industry economic data but reading beyond the surface for a deeper look at what's really going on. We've all read the hyperbolic clickbait articles out there about craft beer's demise, and for the first time in almost twenty years, we saw a net decline in operating breweries in the United States last year. But at the same time, we've been hearing anecdotally from a number of brewers such as Neil Fisher of WeldWerks, in episode 400, that they were growing despite the significant headwinds. This cognitive dissonance got us thinking about how data purport to tell certain truths, but that “truth” is limited by the nature of how data are collected. Craft beer in the United States is both big and small, but our primary sources of data address only the biggest channels of the craft-beer business, leading to distortions in perception that could potentially have damaging effects for craft beer as a whole. With that in mind, Kate sought out some answers to the questions we had—does this meta-narrative we've been reading have truth to it, does it accurately describe the reality that craft brewers are facing, do other data that suggest different or more varied truths, and what can we take away to build a fuller picture of the current state of craft beer? This episode is brought to you by: G&D Chillers (https://gdchillers.com): G&D Chillers Elite 290 Micro-series line utilizes a natural refrigerant, features a more compact design with variable speed fans, and offers near-zero global warming potential. The future of sustainable refrigeration is here! Learn more about G&D's Elite 290 line and visit GDCHILLERS.COM. Berkeley Yeast (https://berkeleyyeast.com). Stop worrying about diacetyl with Berkeley Yeast's line of Fresh™ strains. These revolutionary yeast strains are engineered to produce the ALDC enzyme inside the cell, preventing diacetyl before it forms. That means no more lengthy diacetyl rests—just clean, crisp beer that's ready for packaging sooner. Learn more at berkeleyyeast.com/fresh. Old Orchard (https://www.oldorchard.com/brewer): As breweries expand beyond beer into other segments like mocktails and CBD beverages, Old Orchard is here to help. Whether trending flavor additions or nostalgic favorites, the next best thing is around the corner at Old Orchard. More information and free samples are waiting at oldorchard.com/brewer (https://www.oldorchard.com/brewer) Indie Hops (https://indiehops.com) Strata, Indie's original hop release, is now available in cold-side flowable hop oil form—Strata HyperBoost—in coordination with Yakima Chief Hops. Indie Hops T90 pellets establish the multi-layered Strata experience, while cryogenic CGX pellets in coordination with Crosby Hops, and now Strata HyperBoost with YCH expand the possibilities. Learn more about Strata and Indie's more recent hop releases at www.indiehops.com. Ss Brewtech (https://www.ssbrewtech.com) Featuring a laser-welded cooling jacket for efficient and precise temperature control, an innovative silicone racking arm, and a carbonation stone that allows you to carbonate right in the fermenter, Unitank 2.0 is engineered to help you get the most out of your fermentations! Visit Ss Brewtech.com (https://www.ssbrewtech.com) to learn more! Isuzu Trucks (https://www.isuzucv.com) Whether you are looking for a self-distribution solution or one to deliver supplies, there is an Isuzu truck that will fit your needs. Go to isuzucv.com (https://www.isuzucv.com) to check out their impressive lineup or visit an Isuzu dealer today to find out why now, more than ever, Isuzu trucks are the trucks you trust for the work you do! Cytiva (https://info.cytivalifesciences.com/sample-request-brewing.html) Protecting your beer's highest quality is crucial to maintain its unique taste and prevent spoilage organisms, and microbiological testing plays a vital role in this process. Cytiva offers a comprehensive portfolio of laboratory filtration products designed for both lab and production-floor use. Brewery Workshop (https://breweryworkshop.com) If you're launching a brewery or acquiring an existing one, consider our brewery workshop and new brewery accelerator, September 14 through 17th in Fort Collins, Colorado. Visit breweryworkshop.com for more information and to secure your spot.

From their tiny outpost in the ski town of Park City, Offset Bier (https://offsetbier.com) has turned Utah's challenges—such as a ban on serving draft beer higher than 5 percent ABV—into opportunities. Last year was a breakout one for the budding brewery—we named their session IPA Dopo one of our Best 20 Beers in 2024 (https://beerandbrewing.com/the-best-20-beers-in-2024), while another session IPA, Divi, won gold medal at Great American Beer Festival. Necessity is truly the mother of invention, and the constraints placed upon founder Conor Brown force creative problem solving, as he pulls from various corners of the brewing playbook—European lager and hefeweizen, British ale, and more—for processes and creative angles that drive flavorful, aroma-led hazy LIPAs, or “Lie-PAs.” In this episode, Brown covers: mash steps to promote foam-positive proteins and body in hazy IPAs made from 100 percent barley malt dialing in water chemistry with calcium targets, sodium, and sulfate more than chloride using chit malt in lieu of oats or wheat, and selecting low-FAN pilsner malt embracing small amounts of crystal malts managing DMS reduction at altitude the benefit of boiling hops with longer additions creating texture through hop choices such as American Nobles developing exacting pH targets at each stage of the brewing process And more. This episode is brought to you by: G&D Chillers (https://gdchillers.com): G&D Chillers Elite 290 Micro-series line utilizes a natural refrigerant, features a more compact design with variable speed fans, and offers near-zero global warming potential. The future of sustainable refrigeration is here! Learn more about G&D's Elite 290 line and visit GDCHILLERS.COM. Berkeley Yeast (https://berkeleyyeast.com). Stop worrying about diacetyl with Berkeley Yeast's line of Fresh™ strains. These revolutionary yeast strains are engineered to produce the ALDC enzyme inside the cell, preventing diacetyl before it forms. That means no more lengthy diacetyl rests—just clean, crisp beer that's ready for packaging sooner. Learn more at berkeleyyeast.com/fresh. Old Orchard (https://www.oldorchard.com/brewer): As breweries expand beyond beer into other segments like mocktails and CBD beverages, Old Orchard is here to help. Whether trending flavor additions or nostalgic favorites, the next best thing is around the corner at Old Orchard. More information and free samples are waiting at oldorchard.com/brewer (https://www.oldorchard.com/brewer) Indie Hops (https://indiehops.com) Strata, Indie's original hop release, is now available in cold-side flowable hop oil form—Strata HyperBoost—in coordination with Yakima Chief Hops. Indie Hops T90 pellets establish the multi-layered Strata experience, while cryogenic CGX pellets in coordination with Crosby Hops, and now Strata HyperBoost with YCH expand the possibilities. Learn more about Strata and Indie's more recent hop releases at www.indiehops.com. Ss Brewtech (https://www.ssbrewtech.com) Featuring a laser-welded cooling jacket for efficient and precise temperature control, an innovative silicone racking arm, and a carbonation stone that allows you to carbonate right in the fermenter, Unitank 2.0 is engineered to help you get the most out of your fermentations! Visit Ss Brewtech.com (https://www.ssbrewtech.com) to learn more! Isuzu Trucks (https://www.isuzucv.com) Whether you are looking for a self-distribution solution or one to deliver supplies, there is an Isuzu truck that will fit your needs. Go to isuzucv.com (https://www.isuzucv.com) to check out their impressive lineup or visit an Isuzu dealer today to find out why now, more than ever, Isuzu trucks are the trucks you trust for the work you do! Cytiva (https://info.cytivalifesciences.com/sample-request-brewing.html) Protecting your beer's highest quality is crucial to maintain its unique taste and prevent spoilage organisms, and microbiological testing plays a vital role in this process. Cytiva offers a comprehensive portfolio of laboratory filtration products designed for both lab and production-floor use. Brewer's Retreat (https://brewersretreat.com) Tickets for the Craft Beer & Brewing 2025 Brewer's Retreat in Asheville and Mills River, North Carolina are on sale now and going fast. Brew on homebrew systems with some of the most inspiring craft brewers in the U.S. Learn more and secure your tickets at brewersretreat.com

Strong brewing communities produce clusters of great breweries, and the Colorado brewing world, centered in Denver, is no different. Friendly competition drives innovation, exploration, and refinement as well as knowledgeable consumers with higher and higher expectations, and in this episode, we brought together three friends (each medal-winning brewers) for a conversation on their approach to West coast IPA. Brian Hutchinson of Cannonball Creek (http://www.cannonballcreekbrewing.com) has brought home a slew of medals in the pale ale space (11 total GABF and World Beer Cup medals between their pale ale and session IPA), and picked up a GABF gold medal last year for their New Zealand-style IPA. Jake Gardner of Westbound & Down (https://westboundanddown.com) has earned a handful of GABF and World Beer Cup medals for their West coast IPAs like Spirit of the West and Westbound Select. And Phil Joyce of Amalgam (https://www.amalgambrewing.com) most recently brought home gold for West coast IPA in the Colorado Brewers Cup, after placing fourth at the Alpha King Challenge last year. In this episode, the three move through a range of IPA brewing topics, including: designing IPA with clean flavors that are easy to linguistically identify decocting and step mashing WCIPA for higher attenuation, foam stability, and FAN uptake building a malt base in WCIPA with blends of Pilsner malt using flaked wheat in smaller percentages for mouthfeel fermenting with Chico yeast for dry and low-ester beers minimizing hop creep with ALDC, diacetyl-free yeast, and other yeast health tools driving faster and healthier fermentations for more vibrant hop character understand the impact of water on WCIPA integrating flavor and bitterness the impact of pH on hop expression selecting loud hops that punch hard And more. This episode is brought to you by: G&D Chillers (https://gdchillers.com): G&D Chillers Elite 290 Micro-series line utilizes a natural refrigerant, features a more compact design with variable speed fans, and offers near-zero global warming potential. The future of sustainable refrigeration is here! Learn more about G&D's Elite 290 line and visit GDCHILLERS.COM. Berkeley Yeast (https://berkeleyyeast.com). Stop worrying about diacetyl with Berkeley Yeast's line of Fresh™ strains. These revolutionary yeast strains are engineered to produce the ALDC enzyme inside the cell, preventing diacetyl before it forms. That means no more lengthy diacetyl rests—just clean, crisp beer that's ready for packaging sooner. Learn more at berkeleyyeast.com/fresh. Old Orchard (https://www.oldorchard.com/brewer): As breweries expand beyond beer into other segments like mocktails and CBD beverages, Old Orchard is here to help. Whether trending flavor additions or nostalgic favorites, the next best thing is around the corner at Old Orchard. More information and free samples are waiting at oldorchard.com/brewer (https://www.oldorchard.com/brewer) Indie Hops (https://indiehops.com) Strata, Indie's original hop release, is now available in cold-side flowable hop oil form—Strata HyperBoost—in coordination with Yakima Chief Hops. Indie Hops T90 pellets establish the multi-layered Strata experience, while cryogenic CGX pellets in coordination with Crosby Hops, and now Strata HyperBoost with YCH expand the possibilities. Learn more about Strata and Indie's more recent hop releases at www.indiehops.com. Ss Brewtech (https://www.ssbrewtech.com) Featuring a laser-welded cooling jacket for efficient and precise temperature control, an innovative silicone racking arm, and a carbonation stone that allows you to carbonate right in the fermenter, Unitank 2.0 is engineered to help you get the most out of your fermentations! Visit Ss Brewtech.com (https://www.ssbrewtech.com) to learn more! Isuzu Trucks (https://www.isuzucv.com) Whether you are looking for a self-distribution solution or one to deliver supplies, there is an Isuzu truck that will fit your needs. Go to isuzucv.com (https://www.isuzucv.com) to check out their impressive lineup or visit an Isuzu dealer today to find out why now, more than ever, Isuzu trucks are the trucks you trust for the work you do! Cytiva (https://info.cytivalifesciences.com/sample-request-brewing.html) Protecting your beer's highest quality is crucial to maintain its unique taste and prevent spoilage organisms, and microbiological testing plays a vital role in this process. Cytiva offers a comprehensive portfolio of laboratory filtration products designed for both lab and production-floor use. Brewer's Retreat (https://brewersretreat.com) Tickets for the Craft Beer & Brewing 2025 Brewer's Retreat in Asheville and Mills River, North Carolina are on sale now and going fast. Brew on homebrew systems with some of the most inspiring craft brewers in the U.S. Learn more and secure your tickets at brewersretreat.com

In our latest issue, Louisville's Atrium Brewing (https://www.atriumbrewing.com) scored a category-leading 98 for their barrel-aged stout Denny-Lou, Blend 1, and that was as good a reason as any to check in with cofounder Mark Rubenstein and head brewer Spencer Guy for some background on brewing stouts. Their proximity to some of the best distillers in the Western hemisphere informs their approach to both aging and blending, and they take the same iterative approach to building flavor in more ingredient-laden beers. In this episode, they touch on: brewing flavored imperial stout as well as barrel-aged stout using a reiterated mash in lieu of longer boils for higher starting gravity building lower color stout with very low bitterness to let coffee shine balancing sweetness with tannins in barrel-aged stout blending with multiple stout threads the impacts of brandy and bourbon barrels kettle souring with a hazy IPA grain bill using probiotic beverages for kettle souring adjusting acids in the brite tank for proper fruit expression choosing fruit formats for clarity and quality spinning tanks then bench testing between each ingredient addition to confirm quantities with sensory constructing fruit blends and highlighting with yogurt This episode is brought to you by: G&D Chillers (https://gdchillers.com): G&D Chillers Elite 290 Micro-series line utilizes a natural refrigerant, features a more compact design with variable speed fans, and offers near-zero global warming potential. The future of sustainable refrigeration is here! Learn more about G&D's Elite 290 line and visit GDCHILLERS.COM. Berkeley Yeast (https://berkeleyyeast.com). Stop worrying about diacetyl with Berkeley Yeast's line of Fresh™ strains. These revolutionary yeast strains are engineered to produce the ALDC enzyme inside the cell, preventing diacetyl before it forms. That means no more lengthy diacetyl rests—just clean, crisp beer that's ready for packaging sooner. Learn more at berkeleyyeast.com/fresh. Old Orchard (https://www.oldorchard.com/brewer): As breweries expand beyond beer into other segments like mocktails and CBD beverages, Old Orchard is here to help. Whether trending flavor additions or nostalgic favorites, the next best thing is around the corner at Old Orchard. More information and free samples are waiting at oldorchard.com/brewer (https://www.oldorchard.com/brewer) Indie Hops (https://indiehops.com) Strata, Indie's original hop release, is now available in cold-side flowable hop oil form—Strata HyperBoost—in coordination with Yakima Chief Hops. Indie Hops T90 pellets establish the multi-layered Strata experience, while cryogenic CGX pellets in coordination with Crosby Hops, and now Strata HyperBoost with YCH expand the possibilities. Learn more about Strata and Indie's more recent hop releases at www.indiehops.com. Ss Brewtech (https://www.ssbrewtech.com) Featuring a laser-welded cooling jacket for efficient and precise temperature control, an innovative silicone racking arm, and a carbonation stone that allows you to carbonate right in the fermenter, Unitank 2.0 is engineered to help you get the most out of your fermentations! Visit Ss Brewtech.com (https://www.ssbrewtech.com) to learn more! Isuzu Trucks (https://www.isuzucv.com) Whether you are looking for a self-distribution solution or one to deliver supplies, there is an Isuzu truck that will fit your needs. Go to isuzucv.com (https://www.isuzucv.com) to check out their impressive lineup or visit an Isuzu dealer today to find out why now, more than ever, Isuzu trucks are the trucks you trust for the work you do! Cytiva (https://info.cytivalifesciences.com/sample-request-brewing.html) Protecting your beer's highest quality is crucial to maintain its unique taste and prevent spoilage organisms, and microbiological testing plays a vital role in this process. Cytiva offers a comprehensive portfolio of laboratory filtration products designed for both lab and production-floor use. Brewer's Retreat (https://brewersretreat.com) Tickets for the Craft Beer & Brewing 2025 Brewer's Retreat in Asheville and Mills River, North Carolina are on sale now and going fast. Brew on homebrew systems with some of the most inspiring craft brewers in the U.S. Learn more and secure your tickets at brewersretreat.com

Traditionally, the Chief Financial Officer’s role is predominantly focused on helping companies improve cash flow and profitability. But amid the monumental shift in the landscape of C-suites, today’s CFOs are increasingly being challenged to respond to a much broader definition of value. Christine Tan, Chief Financial Officer, APAC, Cytiva joins The Breakfast Show to discuss what’s driving the evolution of the role of a CFO, how they can overcome transition related barriers and successfully navigate complex challenges in today’s dynamic business environment.See omnystudio.com/listener for privacy information.

Eco-design, collaboration, circular economy. These are the bywords of sustainability in biopharma. Join Ryan Walker, Senior Director of Sustainability at Cytiva, and Aude Arkham, Global Head of Eco Design and Circular Economy at Sanofi, as they explore how eco-design and circular economy initiatives are shaping the future of healthcare. We delve into challenges, achievements, and the transformational potential of sustainability efforts within biopharma. From Sanofi's life cycle assessments to industry-wide data difficulties, this episode navigates the complex landscape of creating greener solutions without compromising innovation and compliance.

Cytiva Bioprocess R&D AB v. JSR Corp.

What does 'the body as a bioreactor' mean? In this discussion how scientists use the body's machinery to produce therapeutic proteins. Scott Ripley, General Manager of Nucleic Acids at Cytiva, explains that traditional bioprocessing uses external bioreactors, while the new approach leverages the body's natural processes. This method offers benefits like longer protein half-life and the ability to express multiple proteins simultaneously. Justin Eyquem, assistant professor at University of California San Francisco, discusses the potential of in vivo CAR T cell therapy, which could simplify manufacturing and reduce costs. Both approaches face challenges in quality assurance and regulatory approval but hold promise for personalized and more effective treatments.

We're diving into advanced therapies with industry leaders. Emmanuel Abate, President of Genomic Medicine at Cytiva discussed the strategies to accelerate clinical work and reduce costs. Nathaniel Wang, CEO and Co-Founder of Replicate Bioscience highlighted their ground breaking self-replicating RNA technology, showcasing impressive clinical results for a rabies vaccine. Both experts emphasized the momentum in biotech, the potential of AI in advancing science, and the importance of making innovative therapies accessible globally. Stay tuned for these insights. Show notes Beneath Everest, a lone caretaker struggles to keep one of the world's highest laboratories alive Integrating human endogenous retroviruses into transcriptome-wide association studies highlights novel risk factors for major psychiatric conditions Keywords: vaccines, advanced therapies, mRNA, manufacturing, technology, patients, innovation, new modalities.

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The promise and growth of cell and gene therapies No sign of stopping: The rise of cell and gene therapy Expert view: What's next for cell and gene therapy? Understanding the future roadmaps of cell and gene therapy Under the microscope: Zoning in on the CGT sector In the first article, DDW's Megan Thomas comments on the state of the CGT industry. In the second, Ryan Leahy, a science communication expert in cell and gene therapy, at Phacilitate, says there is a lot to celebrate but also much to assess, question and challenge in this sector. In the third, DDW's Megan Thomas explores the global innovations in cell and gene therapy and what opportunities and challenges are emerging and can therapies get to market faster. In the fourth, DDW's Megan Thomas caught up with George White, General Manager, Product Management, Cell & Gene Therapy at Cytiva, to learn more about the company's insight into the CGT market. In the fifth and final article, IB Communications' CEO Michelle Boxall explains why there are two sides to the cell and gene therapy coin.

From gene and cell therapies, to the use of CRISPR and other precision engineering technologies, this episode dives into the opportunities and challenges of the emerging field of advanced therapies. On Discovery Matters this week, Dodi and Conor are joined by Daria Donati, Chief Scientific Officer of Genomic Medicine at Cytiva, as well as Jen Moody, Vice President of External Innovation of Genomic Medicines at Danaher, to discuss the science, progress, and potential of advanced therapeutics. Demaris Mills, Group Executive of Genomic Medicines at IDT, and experts Fyodor Urnov, Professor of Molecular and Cell Biology at the University of California, Berkeley, and the Director of Technology & Translation at the Innovative Genomics Institute, cover the technologies used in gene and cell therapies as well as CRISPR to deliver powerful and precise treatments aiming for a healthier future.

In this episode, Dr. Beate Mueller-Tiemann, Chief Technology Officer at Cytiva, joins Fierce Life Sciences's Stephanie Butler. Having spent almost all of her career working within large pharmaceutical enterprises such as Sanofi and Bayer, Beate made the switch to Cytiva in the early part 2023. Her role at Cytiva involves overseeing teams which create and bring high-quality products and innovative manufacturing and R&D processes closer to patients. Beate also keenly supports female talents through participation in mentoring programs. Additionally, she is a member of FiDAR, an association which seeks to increase the representation of women on German corporate boards. During the conversation, Beate discusses her passion for technology and how her career has been defined by working with technology to bring innovation and treatments to patients and improve health outcomes. She also touches on the ongoing work Cytiva is engaged in, as well as the importance of collaboration in driving R&D progress. Tune in to the podcast to learn more. Check out this year's Fierce 50 honorees: https://fierce50.fiercelifesciences.com/See omnystudio.com/listener for privacy information.

How can you bring more humour into all elelemtns of your business?  How can use more humour and light in work and what difference will it make?  We chat this and so much more with the fab Shivani..  Her new comedy show can be watched here!! http://drybarcomedy.com/shivani Follow Shivani: Facebook: Shivani Tamil Comedian Instagram: @igetitfrommyamma LinkedIn: https://www.linkedin.com/in/shivani-nadarajah/ About Shivani Nadarajah: How do you retain and attract diverse talent? Organizations world wide are all working on this initiative without really moving the needle. Shivani Nadarajah, Senior HR Director of Cytiva and part time storytelling comedian believes allyship is the answer to retaining and attracting talent.  Shivani's first comedy special will be released by DryBar comedy early 2024. She has also developed a keynote presentation on “how to tell a work appropriate joke: How to use humor to bring your authentic self to the work place without getting in trouble with HR”

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Clement Fourny, SVP of Commercial at SmartLabs. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Clement, covering: His journey of exploring options and opportunities, which led him to the life sciences space at just the right time Why modular labs and manufacturing suites as a service could provide a de-risked and cost-effective solution to those looking to conserve cash How the SmartLabs turnkey offering enables scientists to focus on the science and not infrastructure The value of building a collaborative ecosystem and community to harness more innovation Clement has a 12-year diverse experience in the Healthcare / Life Sciences industry. Before joining SmartLabs, Clement spent his career at GE and Danaher where he built a track record of strong achievements and execution in sales, commercial operations and operational finance, mobilizing high-performing cross-functional teams to deliver sustainable growth and drive company goals. In his prior role at Cytiva (previously known as GE Life Sciences), Clement was responsible for strategically supporting the global commercial organization of 3,000 associates with best-in-class sales operations services. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

In this podcast, we spoke with Margherita Neri, Director of Vector Process Development, Milan Site at AGC Biologics, Andrew Laskowski, Global Product Manager Bioreactors at Cytiva and Andreia Pedregal, Upstream Applications Specialist Manager at Cytiva about large-scale viral vector manufacturing. Our conversation included discussions around scalability, AAV (adeno-associated virus) and lentivirus production platforms, adherent culture, and next generation bioreactor improvements. I began the interview by asking Margherita about her work at AGC Biologics. She explained that as the Director of the Vector Process Development Unit, her team is responsible for process development of large scale viral vector production for gene therapy applications. Her team is also the first point of contact for new clients. Next, we talked about the types of viral vector platforms that AGC Biologics operates. Margherita described that at their Milan site, they offer AAV (adeno associated virus) and lentiviral vector production platforms in adhesion and in suspension, at 50-to-200-liter scale with expansion planned for up to 1,000 liters. I then asked her about some of the differences between adherent cell culture and suspension cell culture paths to commercial manufacturing. Margherita said that the first consideration is that most clinical trials in gene therapy have been sustained with vector produced from adherent cells, typically via processes performed using Cell Factory™ or Cell STACK®. Now that those gene therapy products are being commercialized, manufacturers need to increase scale and demonstrate comparability using a minimal comparability exercise. So, systems that allow adherent scale up are very useful in this process. Suspension processes are appealing from a scalability point of view because historically they were used for traditional protein bioproductions which can be scaled up to 20,000 – 30,000 liters. Of course, this scale still needs to be demonstrated for vector production that is performed mainly using transient transfection at 200-500 liter scale for lentivirus and between 500-to-1,000-liter maximum scale for AAV. Margherita went on to say that another important aspect in comparability between adherent and suspension systems is quality of the vector in terms of impurity profiles. She said that with adherent processes, cells are attached to the growth support, and the levels of host cell protein and cell DNA are lower when compared to suspension processes. This is very important for lentiviral vector production that is used in vivo where the requirements for impurity levels are very challenging, especially considering that for lentiviral vectors there is currently no affinity step for purification. I followed up by asking her how AGC Biologics can help customers that want to stay in adherent culture to scale up from current processes, for instance, from flatware to larger-scale production. She explained that when customers ask for a scale increase, they usually offer the iCELLis™ platform. First, they demonstrate at small scale the feasibility of the transition from flatware to the iCELLis bioreactor using the iCELLis Nano bioreactor. Using the iCELLis Nano bioreactor, AGC Biologics has developed a full upstream and downstream process that is highly representative of their process using the full-scale iCELLis bioreactor. AGC Biologics can then propose that customers use the vector produced in the iCELLis scale-down model to perform a comparability study between a clinical vector and the future commercial or large-scale vector. This comparability should be based not only on the comparison of titers, residuals, and all the CQA, but also AGC Biologics suggests performing a test of cell transduction on the target cells (i.e. CD34 or T cells) and evaluation on these cells of transfection efficiency – vector copy number, residuals and functionality. I followed up by asking Margherita about whether the iCEL...

Good day to our listeners! In today's episode, we're bringing you several exciting updates from the world of pharma and biotech. Let's dive right in.First up, we're talking about a game-changing webinar hosted by Cytiva. They're discussing a revolutionary, scalable process for producing clinical-grade plasmid DNA. This method is not only efficient but also reduces the purification steps significantly. If you're interested in the intricacies of genomic medicines, this is something you won't want to miss.In the world of health insurance, there's a buzz about Cigna and Humana potentially merging. This could be a major shake-up for the industry, but it's not without its challenges, especially on the regulatory front. Speaking of challenges, UnitedHealth's Medicare Advantage growth for 2024 could hit a snag, and Providence is still grappling with losses despite their recovery efforts. On a brighter note, Highmark Health's insurance business is making waves with boosted earnings, though Allegheny Health's operational losses are a concern. And in a concerning update, an additional 330,000 Medicare beneficiaries might have been affected by a data breach at a federal contractor. Definitely something to keep an eye on.Now, let's shift gears to A/B testing and experimentation programs. A new report, which analyzed data from over 127,000 experiments, sheds light on why many tests don't hit statistical significance and how we can look beyond revenue to other impactful metrics. If you're into data and analytics, this report is a treasure trove of insights.Patient retention in clinical trials is another hot topic we're covering. It's becoming increasingly clear that a patient-centered approach is key to not just getting patients into trials but keeping them there. The challenges range from the impact of trial locations to the feasibility of travel for patients. It's a complex issue, but solutions like telemedicine and local trial centers could be game-changers.For those interested in oncology, there's an upcoming webinar you won't want to miss. It focuses on making cancer studies more efficient and inclusive. The talk will cover innovative strategies, including the use of real-world data and technology, to improve outcomes in oncology research.Shifting our focus to retail health, we're seeing how on-premise digital screens are transforming patient care and driving revenue growth. These screens aren't just about display; they're a strategic tool for enhancing patient experiences and boosting business performance.And lastly, let's touch on some key developments in the pharmaceutical industry. We're looking at an international tax effort impacting big pharma, the potential Cigna-Humana merger, and some exciting updates from Novartis, BioMarin, Novo Nordisk, GSK, and Regeneron and Sanofi. There's a lot happening, and it's all pointing towards an exciting future for the industry.That's all for today's episode. Thanks for joining us on Pharma and Biotech Daily. Don't forget to subscribe for the latest news and updates in the industry. Have a fantastic day!

Comment concilier volontariat et impact professionnel ? Clotilde Dercourt, directrice des relations sociales chez Cytiva, partage son expérience de volontariat. Animée par le désir d'être utile, elle a profité d'une transition professionnelle pour s'engager avec Planète Urgence au Cameroun en 2021. Cette association, active depuis plus de 20 ans, mise sur le volontariat pour la préservation de l'environnement et le développement des communautés. Clotilde, mère de quatre enfants, valorise l'agilité et l'adaptation. Pour elle, le volontariat est une voie d'enrichissement personnel et professionnel. Malgré les défis de la formation dans des conditions variées, elle et les bénéficiaires ont démontré résilience et ingéniosité. Elle voit le volontariat comme une chance de renouer avec des valeurs essentielles et croit en l'importance de donner sans attendre en retour. Clotilde nous pousse à réfléchir à notre engagement et à notre contribution aux enjeux mondiaux, offrant une perspective sincère et inspirante sur le volontariat.Cet épisode a été réalisé en partenariat avec Planète Urgence, l'ONG fondatrice du Congé Solidaire®. Time codes : 0''40 : Introduction1''40 : Le Congé Solidaire®2''10 : Le parcours de Clotilde4''30 : Impact et enseignements7''20 : Importance de l'adaptation9''15 : Conseils pour se lancer11''35 : Les astuces de Clotilde Liens de l'épisode :Les missions de volontariat de Planète UrgenceLe compte LinkedIn de Clotilde DercourtLe compte LinkedIn d'Amandine Hersant

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. Today, we have some exciting news to share with you.## Cytiva's Optimized Method for Analyzing AAV CapsidsCytiva, formerly known as Pall Life Sciences, has developed an optimized method for analyzing adeno-associated virus (AAV) capsids. This method is fast, robust, and cost-efficient, addressing the limitations of current options. The optimized method uses anion exchange chromatography (AEX) with Capto Q chromatography resin to separate empty and full capsids. It has been successfully applied to various serotypes, achieving baseline peak separation. In a recent webinar, Cytiva demonstrated how their method can determine the percentage of full capsids in less than 5 minutes with low sample consumption. This method offers a solution to the challenges faced by process developers and provides a more accurate and cost-effective approach to analyzing AAV capsids.## Real-World Data in Rare Disease ResearchOur next topic is the use of real-world data (RWD) in gaining insights into rare diseases and improving drug development efficiency. RWD expands the insights that clinical trials can provide and helps researchers better understand patients with rare diseases. By analyzing real-world data, researchers can develop new treatments and interventions. However, there are challenges associated with using RWD, such as ensuring data quality and privacy protection. Despite these challenges, leveraging RWD is crucial for optimizing rare disease research.## Johnson & Johnson's Phase III Trial TerminationIn other news, Johnson & Johnson (J&J) has terminated its Phase III trial for Opsumit in pulmonary hypertension based on the recommendation of an independent data monitoring committee. Opsumit is a blockbuster drug for J&J, generating significant revenue for the company. This termination is a setback for J&J, but they continue to explore other opportunities in the field.## Allegations Against Bristol Myers SquibbBristol Myers Squibb (BMS) has been accused by Blue Cross and Blue Shield of Louisiana of conducting patent fraud to sustain a monopoly on its multiple myeloma drug Pomalyst. The healthcare insurance company alleges that BMS fraudulently extended patent protections for Pomalyst, preventing generic versions from entering the market. This case highlights the importance of fair competition and access to affordable treatments.## Roche's Successful Investment in Alnylam PharmaceuticalsOn a positive note, Roche has seen a return on its investment in Alnylam Pharmaceuticals. Alnylam's Phase II trial for its RNA interference therapy for hypertension showed promising results, reducing blood pressure in hypertensive patients. This collaboration between Roche and Alnylam has the potential to lead to innovative treatments for patients.## Astellas Withdraws Lawsuit Against Department of Health and Human ServicesAstellas has withdrawn a lawsuit against the Department of Health and Human Services after its prostate cancer therapy Xtandi was not included in Medicare's initial drug price negotiation list. While disappointed with the decision, Astellas remains committed to working with the government to ensure access to its therapy for Medicare beneficiaries.## Challenges in the Biotech IndustryLastly, the biotech industry is facing challenges as it navigates the post-pandemic markets. The risks are high, with therapeutics potentially failing. It is crucial for the industry to communicate its positive impact and build trust with the public. Recent leadership shakeups at companies like Biogen, Sanofi, and Bristol Myers Squibb highlight the need for stability and improvement within the industry.That's all for today's episode. Thank you for tuning in to Pharma and Biotech Daily, where we bring you the most important news in the world of Pharma and Biotech. Stay tuned for our next episode, and have

Translational research cannot be conducted in a vacuum. For a translational researcher to be successful, they need to build strong relationships with individuals, companies, and institutions that will provide useful support and expertise. In this episode, Linda Mathiasson, Strategic Customer Leader for Nucleic Acid Therapeutics at Cytiva, discusses the flourishing translational field of mRNA therapies and opportunities for researchers to form worthwhile partnerships that support their therapeutic endeavors.   Welcome to Building Bridges for Translational Research, a special edition podcast series produced by The Scientist's Creative Services Team. This series is brought to you by Cytiva, a global provider of technologies and services that advance and accelerate therapeutic development, manufacturing, and delivery. To take preclinical concepts to the market, translational researchers must build strong relationships and forge fruitful partnerships that support their work. In this podcast series, Niki Spahich from The Scientist's Creative Services Team talks to groundbreaking translational researchers and industry experts about their experiences developing technologies and therapies for improving human health and our world at large.

In this episode, Guangping Gao, professor and director of the Horae Gene Therapy Center at the University of Massachusetts Medical School, speaks about developing human gene therapies using recombinant adeno-associated viral vectors, scaling up these therapies, and the future of translational research.   Welcome to Building Bridges for Translational Research, a special edition podcast series produced by The Scientist's Creative Services Team. This series is brought to you by Cytiva, a global provider of technologies and services that advance and accelerate therapeutic development, manufacturing, and delivery. To take preclinical concepts to the market, translational researchers must build strong relationships and forge fruitful partnerships that support their work. In this podcast series, Niki Spahich from The Scientist's Creative Services Team talks to groundbreaking translational researchers and industry experts about their experiences developing technologies and therapies for improving human health and our world at large.

Welcome to Building Bridges for Translational Research, a special edition podcast series produced by The Scientist's Creative Services Team. This series is brought to you by Cytiva, a global provider of technologies and services that advance and accelerate therapeutic development, manufacturing, and delivery. To take preclinical concepts to the market, translational researchers must build strong relationships and forge fruitful partnerships that support their work. In this podcast series, Niki Spahich from The Scientist's Creative Services Team talks to groundbreaking translational researchers and industry experts about their experiences developing technologies and therapies for improving human health and our world at large.   In this episode, serial entrepreneur George Church, professor of genetics and leader of synthetic biology at Harvard's Wyss Institute, talks about his gene editing research and his strategy for spinning translational projects into start-up companies.

Within the life sciences industry, there has been a longstanding conversation around one of the industry's most difficult challenges. That challenge is talent. In more detail, it is that the access to a global talent pool remains difficult. In this longer than usual conversation, Conor and Dodi speak with Darrin Morrissey, CEO of NIBRT, Anne-Cecile Potmans, general manager of Fast Trak and CDMO services at Cytiva, and Nikki Soares, global talent acquisition leader at Cytiva. We discuss how the industry is stepping up its resilience for customers and patients. To find, train, retrain, and retain talent is what matters in this episode of Discovery Matters. Keywords: talent, organization, people, biopharma, industry, life sciences industry, training, global, retaining, companies, skills.

For episode 18 of the Ori Spotlight Podcast, Jason C. Foster is joined by Ori's very own Chief Technology Officer, Stuart Milne. Stuart has extensive experience in the CGT sector, having held leadership positions across R&D, startups and scale-ups – including leading a multidisciplinary CGT R&D team from start-up (Asymptote, 2012) through to acquisition (GE Healthcare, 2017) and divestiture (Cytiva, 2020), and launching IOT-enabled products in CGT. Together, Jason and Stuart discuss how the industry is overcoming current manufacturing challenges, the need to build in quality throughout the development and manufacturing process, and how Ori is preparing now to be able to meet the future demands of customers, the supply chain and regulators. Learn more about Stuart Milne: LinkedIn

In this podcast, we spoke with Dr. Brad Taylor from Nucleus Biologics and Randy Jacinto from Cytiva about the benefits of using a custom media for cell and gene therapy process development. Topics included current development challenges, increases in the number of cell and gene therapies in clinical trials, and employing custom cell culture media solutions to address these issues. We started the discussion by talking about the most pressing challenges facing cell and gene therapy development. Randy began by explaining that the most pressing challenges are the cost of manufacturing, lower than expected adoption rates, and complex logistics around supply chain. At Cytiva, he shared that they are addressing these challenges by automating many parts of the workflow and simplifying the logistics. In addition, the recent partnership with Nucleus Biologics will allow customers easy access to cell culture media solutions that can help accelerate the development of these cell therapies. Brad added that he also hears from customers that there is difficulty accessing consistent, reliable products and materials in single source situations. Companies are working with suppliers who guard their materials with trade secrets and this hinders the ability for that therapy to progress to the clinic. He went on to say that the scalability of cell therapies is also an issue, particularly as the industry moves into allogeneic therapies where manufacturing requires larger scale processes. He stressed that at Nucleus and in conjunction with Cytiva, they are committed to making sure that customers have a consistent supply of reagents and cell culture media to help them meet the rigorous quality standards. Next, I asked about what potential issues will arise with the large increase in cell and gene therapies in clinical trials, and the forecasted further increase over the next five years. Brad said that the regulatory approvals of cell therapies is really accelerating globally. Scaling processes for allogeneic therapies certainly lends itself to custom development and custom process development. So, it is important to not be locked into one size fits all type models. Nucleus wants to make sure that developers of these complex therapies can derisk their processes. Developers want to be able to accentuate desired attributes of their cell therapies and reduce those that are not desirable and cell culture media can have a profound impact in this area. He went on to describe a collaboration with the University of Pennsylvania, where Nucleus demonstrated that individual components can help expedite therapies and improve outcomes. In those publications, authors were able to show an increase in in vivo efficacy, cytotoxicity, and transduction efficiency by changing the cell culture media components for CAR T cells. Randy added that in addition to the scalability challenges, another primary challenge around cell therapies is the labor cost. Cytiva has estimated that labor costs contribute close to 48% of the total manufacturing costs of the drug therapy. To address these labor costs, Cytiva is working through automation as well as digitalization of the workflow and this will help overall improve the scalability and reduce costs. In addition, Cytiva is working with Nucleus Biologics because they truly believe that custom media is a key component in improving the overall efficacy of that drug therapy. Next, I asked about the focus of the Cytiva and Nucleus Biologics collaboration agreement and what they hoped to achieve together. Randy explained that it could not be a better partnership because the companies share a common vision of advancing novel therapeutics like cell therapies, which they believe will have a true transformative impact on the healthcare landscape. He went on to say that the challenge has been with science workflows advancing much faster than the actual process of manufacturing itself.

Emmanuel Ligner, CEO of self-described bioprocess critical actor Cytiva, talks us through the changing biomanufacturing landscape and unveils his firm's sustainability report during a fireside chat at the BioProcess International Theater at BIO in June

On this, the 100th episode of the Business of Biotech podcast, our dear friend, frequent guest, and business of biotech brainiac Allan Shaw joins us to dissect the beleaguered biotech capital markets. We pick apart what's driving sentiment, whether the industry is over-inventoried, what's getting funded , what's not, and why, and what biotech leaders should be doing in an investment landscape marked by hyper-discernment. We also reflect on the podcast journey and celebrate the 100-episode milestone!The Business of Biotech is produced by Bioprocess Online in partnership with Cytiva. 

The workforce is looking to fill its talent pipeline. Modern learners are looking for fast and efficient ways to upskill and reskill to stay relevant in the job market. On this episode, with Steve Pratt, Head of Engineering at Cytiva Vancouver, talks about the employer perspective on the current labor market and how to create a lifelong learning ecosystem fit for the modern learner.  

We talk a lot about beginnings on Discovery Matters, but what about actually getting biologic drugs to people? Once the biologic is produced, aseptic filling and hybrid glass and plastic vials help to protect the biologic drug and the patient. Join Dodi, Conor and their guests, Chris Weikart the Chief Scientist at SiO2 Material Science, and Ross Gold one of the founders of Cytiva's aseptic filling business, in the latest episode of Discovery Matters, talking about the end of the workflow.

Gurus, why should you and your team have a 360⁰ approach to technology? What are the key aspects to this approach? What are some of the best practices that came out of Covid that helped deliver significant results quicker? What are some of the essential best practices to developing a culture of innovation? In this episode Daria Donati, PhD. Head of Business Development & Strategic Technology Partnerships at Cytiva gets into this and more!

How do you solve linked murders without witnesses? The answer, DNA. In this episode of Discovery Matters, we have been inspired by the true crime genre. We discuss a 32-year-old cold case which was the first to be solved with DNA profiling, and a murder in Las Vegas that was solved with the smallest amount of DNA ever! Join Dodi and Conor, and guest Kathryn Lamerton a former forensic scientist currently a Senior R&D Scientist at Cytiva, with a re-enactment helped by some of our colleagues at Cytiva for this exciting episode of Discovery Matters.

Sure, healthcare and pharma does a whole lot of good in the world - but this doesn't make us exempt from taking our plastic waste seriously. So join Conor and Dodi as they talk about the 5 R's with their guests: Tom Szaky, Founder and CEO at TerraCycle; Cristina Peixoto, Head of Lab at iBET (Instituto de Biologia Experimental e Tecnologica, Portugal) and Joëlle Cristofani from Cytiva.

Adam Ligeralde is a scientist-turned-sales rep for a life sciences company called Cytiva, a global provider of technologies & services that advance & accelerate the development & manufacture of therapeutics. Located on the banks of the Hudson River across lower Manhattan, Adam is currently the Technical Sales Specialist for the NY/NJ/PA area for scientists doing anywhere from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell & gene therapies. His fundamental role is to supply the tools & services that researchers need to work better, faster & safer, leading to better patient outcomes. Adam's path into sales was circuitous & serendipitous in his 29 years in the company, starting out in the lab to technical support and then to Marketing & Field Applications before becoming the NYC sales rep. Adam was initially hesitant about getting into sales after having preconceived notions of sales reps like those portrayed in movies like "Love & Other Drugs" or "The Wolf of Wall Street" where its all about the hard sell at any cost. However, because of wonderful mentors & role models, Adam has developed his own style of sales that works quite well in the scientific community by building technical credibility and thereby trust for long-lasting relationships. Learn more about your ad choices. Visit megaphone.fm/adchoices

EAZYSENSE SHOW-58! Easysense is helping people and animals through the Pandemic! Guest- Nada from Med 10000!We're back! We're on the air! A tech glitch got us again and again! No worries! Tune in tonight!Type - Bold Brave Media- in your search engine and search either Dr. Broderick or Eazysense click listen-it's in the upper right hand corner- we're on at 7-PM Eastern! I must hurry-Enjoy!The Eazysense Show is archived! This is our 58th Show and going strong, Thankfully! My best wishes, Dr. Broderick, Host.Tonight's Show on the 6th of January, 2021! Reconstructing a PandemicResearchers estimate that a biotech conference in February led to hundreds of thousands of infections. What can that teach us about the spread of COVID-19?By Benjamin Wallace-Wells December 17, 2020and monoclonal antibodies; synthetic messenger Ribonucleic Acid- Emergency Use Authorization-Montefiore, Einstein and Wakefield-Eli Lilly, Regeneron, Pfizer are important players! Moderna and Cytiva are very much in the Race!A positive attitude is essential!Dr. Patricia A. Broderick, Medical Professor CUNY School of Medicine, CCNYbroderick@med.cuny.eduWebsites: https://www.ccny.cuny.edu/profiles/patricia-broderickhttps://www.eazysensenanotechnology.comhttps://www.eazysensationalbrainimaging.comhttps://www.eazysense.com

Although the COVID-19 pandemic dominated the headlines  in 2020, there were other key developments in 2020. In this year in review, we look at the other key developments in 2020, including new product approvals, noteworthy deals, and other developments making the news. For the text version of this article visit dcatvci.org.Key topics: (see Chapter Markers)2020 in Review: The Top 10 Developments1.      Volume growth of pharmaceuticals declines globally.2.      New molecular entities approvals by FDA keeps pace with prior years.3.      The new AbbVie: AbbVie's $63-Bn acquisition of Allergan.4.      Viatris  launches as new company: Mylan plus Upjohn, Pfizer's off-patent branded and generic established medicines business.5.      Gilead Sciences' $21-Bn acquisition of Immunomedics6.      Danaher's $21.4-Bn acquisition of GE Healthcare Life Sciences and launch of Cytiva. 7.      Merck & Co.'s pending spin-off of women's health, biosimilars & legacy products to form a new company.8.      Reshoring drug manufacturing gains policy momentum.9.      Some drug pricing reforms in the US move forward10.   Brexit uncertainty still looms.Sponsor: Vetter Pharma International GmbHLinks:Subscribe to our e-newsletter at www.dcatvci.orgFollow us on Twitter @DCATvciSupport the show (https://dcat.org/MemberApplication.htm)

Dodi Axelson explains how Cytiva (formerly GE Healthcare Life Sciences) thinks about heir podcast.

Dodi Axelson explains how Cytiva (formerly GE Healthcare Life Sciences) thinks about heir podcast. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit cclifescience.substack.com

Join us to learn about advice for life sciences, data, and other career fields with Mridula Parulkar, a business support data lead at Cytiva! Mridula Parulkar's Excel Tip: Don't limit yourself. When you give yourself the chance to explore new passions and educational pathways, you are better able to narrow down and enjoy a career, rather than working under constant stress and no foreseeable goal or motivation. Below are some links to better understand the terminology and information our guest discusses regarding ERP systems such as Oracle and Salesforce, which might not be as widely known by students, and more information about Ms. Parulkar's company. Feel free to ask us questions on our website for any other information we discuss. https://www.oracle.com/applications/erp/what-is-erp.html https://www.salesforce.com/products/what-is-salesforce/ https://www.cytivalifesciences.com/en/us/about-us --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app